ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0815

Intermittent Fasting Reduces Crystal-induced Inflammation

Nghia Pham1, Twinu Wilson Chirayath2, Florence Castelli3, François Fenaille3, Anvi-Laetitia Nguyen3, François Brial4, Augustin Latourte4, Frédéric Lioté4, Pascal Richette5, Thomas Bardin6 and Hang Korng EA7, 1INSERM 1132, BIOSCAR, Lariboisière hospital, Paris, France, 2INSERM, Paris, France, 3Laboratoire d’études du métabolisme des médicaments UMS 28, CEA Saclay, Gif-sur-Yvette, France, 4INSERM 1132, BIOSCAR, Paris, France, 5Lariboisière Hospital, Paris, France, 6Université de Paris Cité, Paris, France, 7INSERM-BIOSCAR, Paris, France

Meeting: ACR Convergence 2023

Keywords: Crystal-induced arthritis, diet, Inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Inflammation induced by monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals depends on interleukin (IL)-1β activated by the NLRP3 inflammasome. The inflammatory response can be modulated by diet, fasting, and caloric restriction.

Ojective: To determine whether intermittent fasting reduces MSU and CPP crystal-induced inflammation.

Methods: Crystal-induced inflammation was assessed using both types of crystals in vivo in the air pouch model in 8-week-old wild-type male mice fed either with a normal ad libitum diet or intermittent fasting (IF) (every over day fast, 2 days during 1 week). Inflammatory cytokine production (IL1β and CXCL-1) was assessed in the pouch lavages and the cellular infiltrate analyzed by histology (H&E staining). Metabolomic analyses were performed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) on air pouch membrane, serum, and liver samples.

In vitro, human monocytes THP-1 were stimulated by sterile synthetic crystals of MSU and CPP while the production of inflammatory cytokines was quantified by ELISA.

To assess the role of glutamine/glutamate metabolism pathway related to IF in microcrystalline disease, the concentrations of glutamine/glutamate in synovial fluids (SF) from patients with gout, CPP-related disease and osteoarthritis (OA) were quantified by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS).

Results: Inflammation induced by MSU and CPP crystals was drastically decreased by IF compared with normal diet: IL-1β (MSU 0.0 vs. 30.0 pg/ml; CPP 0.0 vs. 47.5 pg/ml p< 0.0001); CXCL-1 (MSU 67.5 vs. 186.8 pg/ml, CPP 156.1 vs. 549.5 pg/ml, p< 0.005); as were cell infiltration assessed by number of cells in the air pouch lavages (MSU 0.2 x 106 vs. 1.1 x 106 ; CPP 0.4 x 106 vs 2.9 x 106; p< 0.0001) and membrane histology semi-quantitative score (MSU 0.6 vs 3.0; CPP 0.8 vs 2.7; p< 0.0001).

Reduction of inflammation by IF was associated with significant changes in membrane, serum and liver metabolites. Many metabolic pathways were altered by IF such as galactose, starch, sucrose, aspartate, glutamate, alanine and arginine metabolism. Interestingly, the glutamine and glutamate metabolic pathway was enriched in serum, membrane and liver compartments.

Glutamine/glutamate involvement in microcrystal-induced inflammation was evidenced in SFs. The glutamine/glutamate ratio was decreased in synovial fluids of crystal-related diseases compared to OA (gout 1.4 and CPP 6.1 vs OA 9.4, p< 0.0001 and p< 0.05 respectively).

In vitro, crystal-induced inflammatory cytokine production was decreased by overnight serum deprivation (IL-1β: MSU 1446 vs 5464 pg/ml; CPP 3670 vs 7797 pg/ml, p< 0.005; TNF-α: MSU 7.0 vs 47.0 pg/ml; CPP 15.6 vs 89.3 pg/ml, p< 0.05; IL-8: MSU 2896 vs 9781 pg/ml; CPP 3984 vs 6820 pg/ml, p< 0.01).

Conclusion: Intermittent fasting alleviates crystal-induced inflammation by altering many metabolic pathways, particularly those associated with glutamine and glutamate. Further studies are needed to determine how crystals modulate metabolism and potential anti-inflammatory effects.


Disclosures: N. Pham: None; T. Wilson Chirayath: None; F. Castelli: None; F. Fenaille: None; A. Nguyen: None; F. Brial: None; A. Latourte: None; F. Lioté: None; P. Richette: None; T. Bardin: None; H. EA: None.

To cite this abstract in AMA style:

Pham N, Wilson Chirayath T, Castelli F, Fenaille F, Nguyen A, Brial F, Latourte A, Lioté F, Richette P, Bardin T, EA H. Intermittent Fasting Reduces Crystal-induced Inflammation [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/intermittent-fasting-reduces-crystal-induced-inflammation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intermittent-fasting-reduces-crystal-induced-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology